A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Efficacy and Safety of WELCHOL as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus (T2DM).
Phase of Trial: Phase III
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Colesevelam (Primary) ; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Inc
- 10 Jun 2017 Biomarkers information updated
- 17 Jul 2013 Status changed from active, no longer recruiting to completed, based on results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 25 Jun 2013 Results assessing changes in size of lipid particles presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History